Delivery Order SPE2DE24D0013-SPE2D625F3LQL
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,791.90 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and reagents to federal healthcare systems. The work will be performed in Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $3,600 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on September 15, 2025, with an ultimate completion date of September 22, 2025. The contract carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. This delivery order falls under Cepheid's larger Indefinite Delivery Vehicle (IDV) contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $31,775.10 by the Defense Department's Medical Supply Chain organization on April 24, 2025. The contract, designated XPRSMVP-10, has an ultimate completion date of May 1, 2025 and carries no set-aside designation. The work will be performed at Cepheid's Sunnyvale facility. This delivery order falls under one of Cepheid's larger Indefinite Delivery...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $4,447.49 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a continuation of Cepheid's established relationship with federal healthcare and defense...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,024 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, contract number 4569079036, is scheduled for completion by August 20, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no set-aside designation, allowing the company to compete on an unrestricted basis....
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,104 on September 11, 2025, with an ultimate completion date of September 18, 2025. The contract, designated XPRSTREPA-10, was issued by the Medical Supply Chain division of the Defense Logistics Agency with no set-aside designation. The place of performance is Sunnyvale, California, and the low contract value suggests this represents a specific...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $4,620 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency component) on September 5, 2025, with an ultimate completion date of September 12, 2025. The contract, designated XPRS-COV2-10, carries no set-aside designation and represents work to be performed in Sunnyvale, California. This delivery order likely draws from one of Cepheid's two significant Indefinite...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,854.00 by the Medical Supply Chain (a Defense agency) on May 21, 2025, with an ultimate completion date of May 29, 2025. The contract, issued without set-aside designation under contract number GXGBSLBXC-10, is to be performed in Sunnyvale, California. This delivery order represents a discrete procurement action under one of Cepheid's existing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3LQLDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $1,680 firm fixed-price delivery order by the Defense Logistics Agency (operating under the Medical Supply Chain division) on September 15, 2025, with an ultimate completion date of September 22, 2025. This delivery order, numbered 4569460601 and designated GXCDIFF/EPI-10, carries no set-aside designation and will be performed in Sunnyvale, California. The contract represents a continuation of Cepheid's ongoing provision of molecular diagnostic testing solutions to federal agencies, leveraging the company's expertise in advanced diagnostic systems and test kits for infectious diseases and clinical testing. This delivery order likely falls under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts with the Veterans Health Administration, including the substantial $32.8 million single-award IDV with VA Veterans Integrated Service Network 6 (extending through September 30, 2030) or the $2.5 million IDV with VA Veterans Integrated Service Network 21, both of which support molecular diagnostic testing including polymerase chain reaction (PCR) testing for conditions such as COVID-19, influenza, and C. difficile infections. The modest ceiling value of this particular delivery order suggests a limited-quantity procurement, though it reflects Cepheid's established role as a key provider of diagnostic reagents and assays within the federal healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/15/25 |